The Use of a Triple-Emitter, UV-C Energy Disinfection System to Reduce CAUTI and CLABSI Rates

August 17, 2017

According to the CDC, roughly one in every 25 hospitalized patients has at least one healthcare-associated infection (HAI).1 HAIs create significant health risks and cost the healthcare industry billions of dollars each year. 

In 2014, Jersey Shore University Medical Center (JSUMC), which is a part of Hackensack Meridian Health, was experiencing an increase in Catheter-Associated Urinary Tract Infections (CAUTI) and Central Line-Associated Bloodstream Infections (CLABSI) in its Medical Intensive Care Unit (MICU).

In this Whitepaper, sponsored by Surfacide, find out what JSUMC introduced to the patient care environment that would impact the CAUTI and CLABSI rates.

 

 

Helios® by Surfacide is a revolutionary, patented triple emitter UV-C hard surface disinfection system. Designed to precisely target all areas even those hidden by shadows the Helios systems advanced laser mapping technology scans a room, creates a plan, and gets to work. Environments are safely disinfected and ready for use in just one efficient cycle.